Bisrat G. Debeb

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

32h-index3.3kcitations157works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(51), Brain Metastases and Treatment(18), Cancer-related Molecular Pathways(14), Endometriosis Research and Treatment(14), Epigenetics and DNA Methylation(13)

Publications157 total

Retrospective review of metastatic hormone receptor-positive inflammatory breast cancer patients reveals poor responses to cyclin dependent kinase 4/6 inhibition
Breast Cancer Research·2025· 1 citedOpen Access
Figure S2 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Figure S3 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Table S1 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Figure S1 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Data from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Figure S4 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Supplementary Materials and Methods from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Table S2 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
BSBM-01 TARGETING CXCL1 - CXCR2 AXIS BLOCKS BRAIN METASTASIS IN INFLAMMATORY BREAST CANCER
Neuro-Oncology Advances·2025Open Access
Soluble E-cadherin Drives Brain Metastasis in Inflammatory Breast Cancer
2025Open Access
Abstract P5-06-23: NDRG1-AKT signaling promotes tumor stemness in inflammatory breast cancer
Clinical Cancer Research·2025
Abstract PS14-08: Targeting CXCL1-CXCR2 axis blocks brain metastasis in inflammatory breast cancer
Clinical Cancer Research·2025
Abstract P1-03-14: Lympho-Vascularized Breast-Skin Platform for Modeling Lymphovascular Space Invasion in Advanced Breast Cancer
Clinical Cancer Research·2025
Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
Molecular Cancer Therapeutics·2025· 2 citedOpen Access
<i>In Vivo</i> Simvastatin and Brain Radiation in a Model of HER2 <sup>+</sup> Inflammatory Breast Cancer Brain Metastasis
2024· 2 citedOpen Access
Abstract PO2-24-06: Cancer-Associated Fibroblasts Promote Tumor Stemness in Aggressive Breast Cancers via NDRG1
Cancer Research·2024
Abstract PO2-24-03: Soluble E-cadherin promotes inflammatory breast cancer tumorigenesis via PDIA4-mediated suppression of ferroptosis
Cancer Research·2024
Abstract PO2-14-10: A selective MCL-1 inhibitor AZD5991 showed tumor regression in a triple-negative inflammatory breast cancer xenograft model
Cancer Research·2024
Abstract PO2-09-05: Building genomic and transcriptomic data among African American and Black patients with triple-negative inflammatory breast cancer
Cancer Research·2024
page 1 of 8Next →

Frequent Co-authors

Wendy A. Woodward(42), Naoto T. Ueno(27), Savitri Krishnamurthy(15), Richard Larson(15), Lara Lacerda(11), James M. Reuben(11), Massimo Cristofanilli(10), Thomas A. Buchholz(9), Wei Xu(7), Adam R. Wolfe(7), Lei Huo(7), Jay P. Reddy(7), Yun Gong(7), Xiaoding Hu(6), Emilly S. Villodre(6), Debu Tripathy(6), Steven Van Laere(6), Travis Solley(5), Li Li(5), Rachel L. Atkinson(5)